This is a new video release [1] but might have been recorded in September in Madrid at ESMO.
I was interested the see that two of the speakers are from the Royal Marsden Hospital where much important research has been done. The gentleman doing most of the talking is Johann de Bono, & here is a snippet from his ESMO bio [2]:
"Professor de Bono’s research interests are rationally designed molecular targeted therapies and prostate cancer. He works in the clinical drug development Phase I trials program at the Royal Marsden NHS Foundation Trust Hospital, and he has been involved in the early clinical development of more than 100 novel agents—many of which are now approved drugs, including abiraterone, MDV3100 and cabazitaxel for advanced prostate cancer. He led on the first-in-man studies of olaparib that first demonstrated antitumour activity for PARP inhibitors in BRCA carrier patients. Professor de Bono has authored more than 200 peer-reviewed articles and several book chapters."
Interesting discussion.
-Patrick